Marksans Pharma receives USFDA approval for Benzonatate capsules
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
The company announced positive topline data from the Phase 3 ADorable-1 trial
One task, one interaction, one pair, experts advocate
Subscribe To Our Newsletter & Stay Updated